We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRTX
176
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$8.95M 0.14%
211,000
+19,000
+10% +$757K
FFIV icon
177
F5
FFIV
$22.1B
$8.88M 0.14%
54,802
-57,151
-51% -$9.81M
SLAB icon
178
Silicon Laboratories
SLAB
$7.15B
$8.88M 0.14%
112,647
-1,233
-1% -$102K
RY icon
179
Royal Bank of Canada
RY
$291B
$8.82M 0.14%
128,902
-20,743
-14% -$1.51M
AMBA icon
180
Ambarella
AMBA
$2.99B
$8.8M 0.14%
251,480
+51,775
+26% +$1.83M
CNP icon
181
CenterPoint Energy
CNP
$29.1B
$8.79M 0.14%
311,470
+234,720
+306% +$6.55M
RHT
182
DELISTED
Red Hat Inc
RHT
$8.75M 0.13%
49,799
+1,170
+2% +$185K
ZGNX
183
DELISTED
Zogenix, Inc.
ZGNX
$8.59M 0.13%
235,700
+127,000
+117% +$5.2M
GGG icon
184
Graco
GGG
$12.9B
$8.59M 0.13%
205,154
-99,092
-33% -$4.14M
SPPI
185
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$8.57M 0.13%
979,825
+310,725
+46% +$3.96M
AMP icon
186
Ameriprise Financial
AMP
$46.8B
$8.5M 0.13%
81,476
+3,528
+5% +$443K
CSL icon
187
Carlisle Companies
CSL
$13.6B
$8.41M 0.13%
+83,705
New +$8.61M
NEM icon
188
Newmont
NEM
$98.2B
$8.36M 0.13%
241,271
+11,597
+5% +$376K
SYF icon
189
Synchrony
SYF
$23.7B
$8.35M 0.13%
355,941
+3,072
+0.9% +$83.1K
HIG icon
190
Hartford Financial Services
HIG
$38.5B
$8.34M 0.13%
187,654
+151,946
+426% +$6.84M
SHPG
191
DELISTED
Shire pic
SHPG
$8.3M 0.13%
47,698
+33,122
+227% +$5.79M
UNM icon
192
Unum
UNM
$13.8B
$8.06M 0.12%
274,372
-5,040
-2% -$176K
SGEN
193
DELISTED
Seagen Inc. Common Stock
SGEN
$8.01M 0.12%
141,374
+4,174
+3% +$262K
WMB icon
194
Williams Companies
WMB
$90.5B
$8.01M 0.12%
363,041
-149,617
-29% -$3.74M
RF icon
195
Regions Financial
RF
$26.3B
$7.94M 0.12%
593,777
-26,480
-4% -$425K
HOLI
196
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$7.91M 0.12%
451,599
-5,087
-1% -$97K
KMI icon
197
Kinder Morgan
KMI
$73.1B
$7.87M 0.12%
511,732
+206,522
+68% +$3.5M
EBAY icon
198
eBay
EBAY
$48.6B
$7.86M 0.12%
279,918
-107,347
-28% -$3.16M
GAP
199
The Gap Inc
GAP
$6.84B
$7.8M 0.12%
302,895
+75,270
+33% +$2.01M
CBAY
200
DELISTED
Cymabay Therapeutics
CBAY
$7.7M 0.12%
978,000
+20,000
+2% +$190K

Similar funds

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.